The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
The mechanisms leading to degeneration of dopaminergic neurons (DNs) in the substantia nigra of patients with Parkinson's disease (PD) are not completely understood. Here, we show, in the postmortem human tissue, that these neurons aberrantly express mitosis-associated proteins, including the E2F-1 transcription factor, and appear to duplicate their nuclear DNA. We further demonstrate that the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine injected into mice and application of its active metabolite 1-methyl-4-phenylpyridinium to mesencephalic cultures activate the retinoblastoma–E2F pathway in postmitotic DNs. We also find that cell death rather than mitotic division followed the toxin-induced replication of DNA, as determined by BrdU incorporation in DNs. In addition, blocking E2F-1 transcription protected cultured DNs against 1-methyl-4-phenylpyridinium toxicity. Finally, E2F-1-deficient mice were significantly more resistant to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic cell death than their wild-type littermates. Altogether, BrdU incorporation in mature neurons and lack of evidence for newborn neurons argue against neuronal turnover in normal conditions or during pathological states in the substantia nigra. Instead, our results demonstrate that mitosis-like signals are activated in mature DNs in patients with PD and mediate neuronal death in experimental models of the disease. Inhibition of mitosis-like signals may therefore provide strategies for neuroprotection in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another study reported increased levels of the E2F-1 transcription factor in dopaminergic neurons in the substantia nigra of PD patients and suggested that the pRb/E2F-1 pathway is activated in these neurons which can lead to apoptosis [251].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [251]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
E2F-1 Functions in Mice to Promote Apoptosis and Suppress Proliferation
Field, S. J., Tsai, F.-Y., Kuo, F., Zubiaga, A. M., Kaelin, W. G., Livingston, D. M., Orkin, S. H., & Greenberg, M. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81255-6 · Cited by 754
DNA Replication Precedes Neuronal Cell Death in Alzheimer's Disease
Yang, Y., Geldmacher, D. S., & Herrup, K. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02661.2001 · Cited by 616
The harlequin mouse mutation downregulates apoptosis-inducing factor
Klein, J. A., Longo-Guess, C. M., Rossmann, M. P., Seburn, K. L., Hurd, R. E., Frankel, W. N., Bronson, R. T., & Ackerman, S. L. (2002) · Nature · doi:10.1038/nature01034 · Cited by 605
Evidence for neurogenesis in the adult mammalian substantia nigra
Zhao, M., Momma, S., Delfani, K., Carlén, M., Cassidy, R. M., Johansson, C. B., Brismar, H., Shupliakov, O., Frisén, J., & Janson, A. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1131955100 · Cited by 590
Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer’s disease
Yang, Y., Mufson, E. J., & Herrup, K. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02557.2003 · Cited by 483
The Adult Substantia Nigra Contains Progenitor Cells with Neurogenic Potential
Lie, D. C., Dziewczapolski, G., Willhoite, A. R., Kaspar, B. K., Shults, C. W., & Gage, F. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06639.2002 · Cited by 449
Staropoli, J. F., McDermott, C., Martinat, C., Schulman, B., Demireva, E., & Abeliovich, A. (2003) · Neuron · doi:10.1016/s0896-6273(03)00084-9 · Cited by 381
Smith, P. D., Crocker, S. J., Jackson-Lewis, V., Jordan-Sciutto, K. L., Hayley, S., Mount, M. P., O'Hare, M. J., Callaghan, S., Slack, R. S., Przedborski, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2232515100 · Cited by 319
The genetics of the E2F family of transcription factors: shared functions and unique roles
DeGregori, J. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00051-3 · Cited by 295
Self-citation
Cited by
Cell cycle regulation in the postmitotic neuron: oxymoron or new biology?
Herrup, K., & Yang, Y. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2124 · Cited by 507
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
“Another study reported increased levels of the E2F-1 transcription factor in dopaminergic neurons in the substantia nigra of PD patients and suggested that the pRb/E2F-1 pathway is activated in these neurons which can lead to apoptosis [251].”
BackgroundRecent Advances in the Genetics of Parkinson's Disease
Martin, I., Dawson, V. L., & Dawson, T. M. (2011) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082410-101440 · Cited by 437
“In light of the finding that E2F-1 is aberrantly expressed in the brains of PD patients and that inappropriate expression of cell-division proteins in postmitotic neurons may lead to cell death (54), dysregulated translation may represent an important pathogenic output of mutant LRRK2.”
Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression
Gehrke, S., Imai, Y., Sokol, N., & Lu, B. (2010) · Nature · doi:10.1038/nature09191 · Cited by 398
Cell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final steps
Levy, O. A., Malagelada, C., & Greene, L. A. (2009) · Apoptosis · doi:10.1007/s10495-008-0309-3 · Cited by 287
“Cultured midbrain neurons treated with MPP? show immunostaining for phospho-pRB and E2F-1 [210].”
InfluentialYeger-Lotem, E., Riva, L., Su, L. J., Gitler, A. D., Cashikar, A. G., King, O. D., Auluck, P. K., Geddie, M. L., Valastyan, J. S., Karger, D. R., et al. (2009) · Nature Genetics · doi:10.1038/ng.337 · Cited by 286
A miRNA signature of prion induced neurodegeneration.
Saba, R., Goodman, C. D., Huzarewich, R. L. C. H., Robertson, C., & Booth, S. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003652 · Cited by 251
“MAZ is an inflammation-responsive transcription factor that has been colocalized to pathologic structures in Alzheimer’s disease brain while up regulation of E2F1 has been shown to trigger cell cycle re-entry of post-mitotic neurons leading to the initiation of apoptosis in neurodegeneration associated with Parkinson’…”
BackgroundNeuronal cell cycle: the neuron itself and its circumstances
Frade, J. M., & Ovejero-Benito, M. C. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1004937 · Cited by 243
HIV-Associated Neurocognitive Disorder: Pathogenesis and Therapeutic Opportunities
Lindl, K. A., Marks, D. R., Kolson, D. L., & Jordan-Sciutto, K. L. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-010-9205-z · Cited by 241
“Interestingly, cell cycle proteins, such as the transcription factor, E2F1, and its regulator, the retinoblastoma gene product, exhibit increased levels and altered expression patterns in Alzheimer’s Disease (AD), PD, and HAND postmortem tissue (Jordan-Sciutto et al. 2002a, b; Hoglinger et al. 2007).”
BackgroundAtypical E2Fs: new players in the E2F transcription factor family
Lammens, T., Li, J., Leone, G., & De Veylder, L. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.01.002 · Cited by 227
Túnez, I., Tasset, I., Pérez-De La Cruz, V., & Santamaría, A. (2010) · Molecules · doi:10.3390/molecules15020878 · Cited by 220
“3-NP has also been shown to reduce the expression of the p27 cellular cycle inhibitor and increase phosphorilation of the retinoblastoma protein [199], as well as activation of CDK5, which regulates calpain activity [200].”
BackgroundMatusch, A., Depboylu, C., Palm, C., Wu, B., Höglinger, G. U., Schäfer, M. K. H., & Becker, J. S. (2010) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2009.09.022 · Cited by 197
“Wildtype C57Bl6 male mice, 8 to 10 wk old, were injected with 30 mg kg 1 MPTP (3 mg mL 1 saline) or vehicle intra-peritoneally on 5 consecutive d according to [27, 30].”
MethodSelf-citationGenomic integrity and the ageing brain
Chow, H.-M., & Herrup, K. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4020 · Cited by 174
MicroRNAs in Parkinson's disease
Harraz, M. M., Dawson, T. M., & Dawson, V. L. (2011) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2011.01.005 · Cited by 160
Neural cell cycle dysregulation and central nervous system diseases
Wang, W., Bu, B., Xie, M., Zhang, M., Yu, Z., & Tao, D. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.01.007 · Cited by 159
Parkinson's disease and cancer: two wars, one front
Devine, M. J., Plun‐Favreau, H., & Wood, N. W. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3150 · Cited by 170
Podocyte Mitosis - A Catastrophe
Lasagni, L., Lazzeri, E., Shankland, S. J., Anders, H.-J., & Romagnani, P. (2012) · Current Molecular Medicine · doi:10.2174/156652413804486250 · Cited by 146
Role of Cell Cycle Re-Entry in Neurons: A Common Apoptotic Mechanism of Neuronal Cell Death
Folch, J., Junyent, F., Verdaguer, E., Auladell, C., Pizarro, J. G., Beas‐Zárate, C., Pallàs, M., & Camins, A. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9277-4 · Cited by 159
“Interestingly, E2F-1 knock-out mice were protected from MPTP toxicity in vivo, so these data suggest that cell cycle re-entry is an important step in this model of neurotoxicity (Höglinger et al. 2007).”
InfluentialEverything that Glitters Isn't Gold: A Critical Review of Postnatal Neural Precursor Analyses
Breunig, J. J., Arellano, J. I., Macklis, J. D., & RAKIC, P. T. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.11.008 · Cited by 149
Self-citationBhaskar, K., Maphis, N., Xu, G., Varvel, N. H., Kokiko-Cochran, O. N., Weick, J. P., Staugaitis, S. M., Cardona, A., Ransohoff, R. M., Herrup, K., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.10.007 · Cited by 137
The role of the DNA damage response in neuronal development, organization and maintenance
Barzilai, A., Biton, S., & Shiloh, Y. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.03.005 · Cited by 150
Lee, H.-G., Casadesus, G., Zhu, X., Castellani, R. J., McShea, A., Perry, G., Petersen, R. B., Bajic, V., & Smith, M. A. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2008.10.013 · Cited by 131
“Furthermore, injection of dopaminergic neurotoxin 1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) into mice, which has been widely used as a model of Parkinson’s disease, activates the retinoblastoma-E2F pathway in postmitotic dopaminergic neurons (Hoglinger et al., 2007).”
BackgroundCdk5: Multitasking between physiological and pathological conditions
Lopes, J. P., & Agostinho, P. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.03.006 · Cited by 153
“(Insertion of Figure 2) Interestingly, Cdk5 overactivation has been described in several neurodegenerative conditions in which ectopic cell cycle events were also reported (Hoglinger et al., 2007; Lopes et al., 2009b; Nguyen et al., 2003; Wen et al., 2005; Zhang et al., 2010).”
InfluentialmiRNAs: Key Players in Neurodegenerative Disorders and Epilepsy
Karnati, H. K., Panigrahi, M. K., Gutti, R. K., Greig, N. H., & Tamargo, I. A. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-150395 · Cited by 124
Podocyte Mitosis - A Catastrophe
Lasagni, L., Lazzeri, E., Shankland, S. J., Anders, H., & Romagnani, P. (2012) · Current Molecular Medicine · doi:10.2174/1566524011307010013 · Cited by 189
“There are also reports of cell cycle protein reexpression in amyotrophic lateral sclerosis [58], ataxia telangiectasia [59], Parkinson's disease [60], stroke [61] and other neurodegenerative conditions [62].”
BackgroundModi, P. K., Komaravelli, N., Singh, N., & Sharma, P. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-02-0125 · Cited by 127
Molecular crosstalk between cancer and neurodegenerative diseases
Seo, J., & Park, M. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03428-3 · Cited by 114
THAP1 mutations (DYT6) are an additional cause of early-onset dystonia
Houlden, H., Schneider, S. A., Paudel, R., Melchers, A., Schwingenschuh, P., Edwards, M., Hardy, J., & Bhatia, K. P. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d5276d · Cited by 106
Hassan, M., Selimović, D., Ghozlan, H. A., & Abdel-Kader, O. (2009) · Hepatology · doi:10.1002/hep.22849 · Cited by 105
Joseph, C., Mangani, A. S., Gupta, V. B., Chitranshi, N., Shen, T., Dheer, Y., Devaraj, K. B., Mirzaei, M., You, Y., Graham, S. L., et al. (2020) · Aging and Disease · doi:10.14336/ad.2019.0923 · Cited by 108
“PCNA, E2F, Dopaminergic neurons in SN (IHC, IF) G1/S [139]”
BackgroundThe chemokine CXCL12 promotes survival of postmitotic neurons by regulating Rb protein
Khan, M. Z., Brandimarti, R., Shimizu, S., Nicolai, J., Crowe, E. P., & Meucci, O. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.95 · Cited by 101
Molecular correlates of axonal and synaptic pathology in mouse models of Batten disease
Kielar, C., Wishart, T. M., Palmer, A., Dihanich, S., Wong, A. M., Macauley, S. L., Chan, C.-H., Sands, M. S., Pearce, D. A., Cooper, J. D., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp355 · Cited by 93
“For example, numerous examples of cell-cycle regulation gone awry have been reported in neurodegenerative conditions such as motor neuron disease, Alzheimer’s disease, Parkinson’s disease and stroke (40,41,63,64).”
BackgroundKanao, T., Venderova, K., Park, D. S., Unterman, T., Lu, B., & Imai, Y. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq289 · Cited by 91
Selective vulnerability in α-synucleinopathies
Alegre-Abarrategui, J., Brimblecombe, K. R., Roberts, R. F., Velentza-Almpani, E., Tilley, B. S., Bengoa-Vergniory, N., & Proukakis, C. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02010-2 · Cited by 87
Neurodegeneration in an Aβ‐induced model of Alzheimer’s disease: the role of Cdk5
Lopes, J. P., Oliveira, C. R., & Agostinho, P. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2009.00536.x · Cited by 86
“, 2007), there was also the re-expression of different cell cycle markers (Nguyen et al., 2003; Kuan et al., 2004; Hernandez-Ortega et al., 2007; Hoglinger et al., 2007).”
BackgroundInfluentialReview: Somatic mutations in neurodegeneration
Leija‐Salazar, M., Piette, C. E., & Proukakis, C. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12465 · Cited by 93
DNA damage and repair in Parkinson's disease: Recent advances and new opportunities
González-Hunt, C. P., & Sanders, L. H. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24592 · Cited by 84
“Additionally, duplicated DNA has been detected in SN neurons from subjects with PD (Höglinger et al., 2007).”
BackgroundAlquézar, C., Salado, I. G., de la Encarnación, A., Pérez, D. I., Moreno, F., Gil, C., de Munaín, A. L., Martínez, A., & Martín‐Requero, Á. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0102-7 · Cited by 87
Pelegrí, C., Duran‐Vilaregut, J., del Valle, J., Crespo‐Biel, N., Ferrer, I., Pallàs, M., Camins, A., & Vilaplana, J. (2008) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2008.07.016 · Cited by 82
“…ischemia, apoptosis mediated by oxygen–glucose deprivation in cortical and hippocampal cultures, and cell death induced by b-amyloid (Giovanni et al., 1999, 2000; O’Hare et al., 2000; Gendron et al., 2001; Hou et al., 2001a,b; MacManus et al., 2003; Smith et al., 2003; Höglinger et al., 2007).”
BackgroundModelling Parkinson‐like neurodegeneration via osmotic minipump delivery of MPTP and probenecid
Alvarez‐Fischer, D., Guerreiro, S., Hunot, S., Saurini, F., Marien, M., Sokoloff, P., Hirsch, E. C., Hartmann, A., & Michel, P. P. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05651.x · Cited by 75
Self-citationOxidative Stress Diverts tRNA Synthetase to Nucleus for Protection against DNA Damage
Wei, N., Shi, Y., Truong, L. N., Fisch, K. M., Xu, T., Gardiner, E. M. M., Fu, G., Hsu, Y.-S. O., Kishi, S., Su, A. I., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.006 · Cited by 78
“Overactivation of E2F1 can cause aberrant cell-cycle progression and specific neuronal cell death in Parkinson disease (Ho¨glinger et al., 2007) and in inherited deafness associated with mitochondria stress (Raimundo et al., 2012).”
BackgroundMokretar, K., Pease, D., Taanman, J., Soenmez, A., Ejaz, A., Lashley, T., Ling, H., Gentleman, S., Houlden, H., Holton, J. L., et al. (2018) · Brain · doi:10.1093/brain/awy157 · Cited by 84
Smith-Geater, C., Hernandez, S. J., Lim, R. G., Adam, M., Wu, J., Stocksdale, J. T., Wassie, B. T., Gold, M. P., Wang, K. Q., Miramontes, R., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.01.015 · Cited by 74
MicroRNAs in Parkinson’s disease
Singh, A., & Sen, D. (2017) · Experimental Brain Research · doi:10.1007/s00221-017-4989-1 · Cited by 77
“As shown in animal models of PD, upregulation of e2f1 and dp in postmitotic neurons leads to cell death (Höglinger et al. 2007).”
BackgroundCell Cycle Activation and Spinal Cord Injury
Wu, J., Stoica, B. A., & Faden, A. I. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0028-2 · Cited by 73
“However, numerous studies in the last decade have demonstrated that cell cycle re-entry contributes to the death of postmitotic cells [1, 2]. Increasing evidence indicates that cell cycle activation (CCA) is involved in the pathophysiology of both acute and chronic neurodegenerative disorders as follows: cerebral isch…”
Transcriptional control of stem cell fate by E2Fs and pocket proteins
Julian, L. M., & Blais, A. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00161 · Cited by 76
“Concomitantly, activator E2F proteins (E2F1, E2F2, and E2F3) become expressed and stimulate the transcription of cell cycle genes that allow cells to pass the G1/S transition.”
BackgroundTransposable elements as new players in neurodegenerative diseases
Ravel‐Godreuil, C., Znaidi, R., Bonnifet, T., Joshi, R. L., & Fuchs, J. (2021) · FEBS Letters · doi:10.1002/1873-3468.14205 · Cited by 68
Cdk5 acts as a mediator of neuronal cell cycle re-entry triggered by amyloid-β and prion peptides
Lopes, J. P., Oliveira, C. R., & Agostinho, P. (2009) · Cell Cycle · doi:10.4161/cc.8.1.7506 · Cited by 65
MicroRNA profiling and the role of microRNA-132 in neurodegeneration using a rat model
Lungu, G. F., Stoica, G., & Ambrus, A. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.08.001 · Cited by 73
de Boni, L., Tierling, S., Roeber, S., Walter, J., Giese, A., & Kretzschmar, H. A. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-011-8163-9 · Cited by 71
Cell Cycle Activation and CNS Injury
Stoica, B. A., Byrnes, K. R., & Faden, A. I. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9050-0 · Cited by 63
Activation of the calpain/cdk5/p25 pathway in the girus cinguli in Parkinson's disease
Alvira, D., Ferrer, I., Cuesta, J., García‐Castro, B., Pallàs, M., & Camins, A. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.09.005 · Cited by 71
“The present study has also shown increased levels of the transcription factor E2F-1, thus supporting previous reports showing the expression of E2F-1 in PD [22].”
ResultThe Multifaceted Regulation of Mitochondrial Dynamics During Mitosis
Pangou, E., & Sumara, I. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.767221 · Cited by 70
Keeney, J. T. R., Swomley, A. M., Harris, J. L., Fiorini, A., Mitov, M. I., Perluigi, M., Sultana, R., & Butterfield, D. A. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9287-2 · Cited by 62
Tomashevski, A., Webster, D. R., Grammas, P., Gorospe, M., & Kruman, I. I. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.221 · Cited by 57
“In contrast with repairable DNA damage, which only requires progression through early G1, DNA damage leading to neuronal death requires the cell cycle machinery for entry into the S phase and DNA replication in addition to G0→G1 transition (cells cannot enter S phase without G0→G1 transition) [13,29,35–40].”
BackgroundCdk5 Nuclear Localization Is p27-dependent in Nerve Cells
Zhang, J., Li, H., & Herrup, K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.068262 · Cited by 56
Cell‐context specific role of the E2F/Rb pathway in development and disease
Swiss, V. A., & Casaccia, P. (2009) · Glia · doi:10.1002/glia.20933 · Cited by 62
“Aberrant Rb expression (Jordan-Sciutto et al., 2003) and active E2F (Hoglinger et al., 2007) were also detected in Parkinson’s disease and amyotrophic lateral sclerosis (Nguyen et al., 2003; Ranganathan et al., 2001).”
BackgroundWilson, C. L., Murphy, L. B., Leslie, J., Kendrick, S. F. W., French, J., Fox, C. R., Sheerin, N., Fisher, A., Robinson, J. H., TINIAKOS, D. G., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.034 · Cited by 54
“Indeed, diverse roles are described in kidney disease, neurodegeneration and cancer where UCHL1 exerts its effects by influencing levels of free proteins such as cellular Ub, glutathione and by regulation of the cell cycle [13,29–33].”
BackgroundA knowledge-based approach for predicting gene–disease associations
Zhou, H., & Skolnick, J. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw358 · Cited by 57
DNA damage, neuronal and glial cell death and neurodegeneration
Barzilai, A. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0501-0 · Cited by 56
“A typical example is high expression of the transcription factor E2F-1 in the affected tissues [86].”
BackgroundSurvivin: A target from brain cancer to neurodegenerative disease
Baratchi, S., Kanwar, R. K., & Kanwar, J. R. (2010) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2010.516740 · Cited by 54
“A similar situation has been reported in patients suffering from amyotrophic lateral sclerosis (ALS), Parkinson disease (PD), stroke and other neurodegenerative diseases (Jordan-Sciutto et al., 2002; West et al., 2005; Yang and Herrup, 2005; Burns et al., 2007; Hoeglinger et al., 2007).”
BackgroundMachine learning discriminates a movement disorder in a zebrafish model of Parkinson's disease
Hughes, G. L., Lones, M. A., Bedder, M., Currie, P. D., Smith, S. L., & Pownall, M. E. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.045815 · Cited by 60
“dat and th expression were assessed as both are markers of DA neurons; dat is specific to DA neurons, whereas th is expressed in all catecholaminergic neurons (Holzschuh et al., 2001).”
BackgroundE2F1 Works as a Cell Cycle Suppressor in Mature Neurons
Wang, L., Wang, R., & Herrup, K. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3681-07.2007 · Cited by 50
“Furthermore, E2F1-null mice are resistant to neurotoxin-induced dopaminergic cell death than their wild-type littermates (Hoglinger et al., 2007).”
BackgroundInfluentialKabuta, T., Mitsui, T., Takahashi, M., Fujiwara, Y., Kabuta, C., Konya, C., Tsuchiya, Y., Hatanaka, Y., Uchida, K., Hohjoh, H., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.435701 · Cited by 52
“Dysregulation of the cell cycle or CDK5 is also associated with neurodegenerative diseases (5, 6).”
BackgroundMüller, M., Cheung, K., & Foskett, J. K. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3421 · Cited by 55
Marathe, S. V., Liu, S., Brai, E., Kaczarowski, M., & Alberi, L. A. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.23 · Cited by 50
“Activation of E2F1-mediated transcription in neurons upon injury, AD and PD has been reported before and has been associated to neuronal damage.(9,45,46) In our study, we observe that upon KA, the Ccnd1/Rb/E2F1 axis is positively regulated leading to an increase in transcription of PCNA and Cyclin E1 in neurons.”
BackgroundFailure of DNA double-strand break repair by tau mediates Alzheimer’s disease pathology in vitro
Asada‐Utsugi, M., Uemura, K., Ayaki, T., Uemura, M. T., Minamiyama, S., Hikiami, R., Morimura, T., Shodai, A., Ueki, T., Takahashi, R., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03312-0 · Cited by 51
Modularity in Protein Complex and Drug Interactions Reveals New Polypharmacological Properties
Nacher, J. C., & Schwartz, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030028 · Cited by 51
“So far none of these complexes was associated to Parkinson disease; however aberrant activation of the RB1-E2F pathway was observed to mediate neuronal cell death and its inhibition was proposed as a possible strategy for neuroprotection [43].”
BackgroundPérez‐Rodríguez, D., Kalyva, M., Leija‐Salazar, M., Lashley, T., Tarabichi, M., Chelban, V., Gentleman, S., Schottlaender, L., Franklin, H., Vasmatzis, G., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0873-5 · Cited by 56
Wu, D., Sun, J. K., & Chow, H. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002559 · Cited by 57
“In PD-LBD, cell cycle-related events were previously reported in the dopaminergic (DA) neurons of the midbrain and dorsal striatum regions [71].”
BackgroundBahnassawy, L., Nicklas, S., Palm, T., Menzl, I., Birzele, F., Gillardon, F., & Schwamborn, J. C. (2013) · Stem Cells and Development · doi:10.1089/scd.2013.0163 · Cited by 50
“These observations are of special importance, because a knock-down of LRRK2 leads to a similar up-regulation [24] and such aberrant activation of the cell cycle has been linked to neurodegeneration in PD [46].”
Delston, R. B., Matatall, K. A., Sun, Y., Onken, M. D., & Harbour, J. W. (2010) · Oncogene · doi:10.1038/onc.2010.442 · Cited by 54
“…mediates neuronal cell death in multiple neurodegenerative disorders such as Parkinsons disease, Alzheimers disease and stroke (Giovanni et al, 2000; Hayashi et al, 2000; Hoglinger et al, 2007; Liu & Greene, 2001; O'Hare et al, 2000; Park et al, 2000; Ramalho et al, 2004; Thakur et al, 2008).”
BackgroundCoordination of cell cycle exit and differentiation of neuronal progenitors
Politis, P. K., Thomaidou, D., & Matsas, R. (2008) · Cell Cycle · doi:10.4161/cc.7.6.5550 · Cited by 52
Understanding the link between cancer and neurodegeneration
Driver, J. A. (2011) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2011.11.007 · Cited by 47
Corradini, B. R., Iamashita, P., Tampellini, E., Farfel, J. M., Grinberg, L. T., & Moreira‐Filho, C. A. (2014) · BioMed Research International · doi:10.1155/2014/543673 · Cited by 43
“In PD, the Rb-E2F pathway activates mitosis-like signals in dopaminergic neurons of SN pars compacta mediating the death of these cells [114].”
BackgroundWang, H., Dharmalingam, P., Vasquez, V., Mitra, J., Boldogh, I. R., Rao, K. S. J., Kent, T. A., MITRA, S. P., & Hegde, M. L. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.09.005 · Cited by 50
Depboylu, C., Schorlemmer, K., Klietz, M., Oertel, W. H., Weihe, E., Höglinger, G. U., & Schäfer, M. K.-H. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.05.006 · Cited by 47
“5 times (at 24 h intervals on 5 consecutive days) with 30 mg/kg MPTP-HCl (dissolved 3 mg/ml in saline; SigmaAldrich, Deisenhofen, Germany) or vehicle (10 ml/kg) alone (Tatton and Kish, 1997; Höglinger et al., 2007).”
BackgroundSelf-citationWu, J., Sabirzhanov, B., Stoica, B. A., Lipinski, M. M., Zhao, Z., Zhao, S., Ward, N., Yang, D., & Faden, A. I. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1104436 · Cited by 40
“Suppression of E2F1 expression and the use of E2F null mice attenuate neuronal death in in vitro 24-26 and in vivo models of Parkinson disease.(27) We have provided the first evidence for the upregulation of the E2F1 and its target gene CDK1, early after SCI in rat, which was associated with subsequent neuronal apopto…”
MethodPharmacological relevance of CDK inhibitors in Alzheimer's disease
Malhotra, N., Gupta, R. V., & Kumar, P. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105115 · Cited by 43
Hermann, A., Suess, C., Fauser, M., Kanzler, S., Witt, M., Fabel, K., Schwarz, J., Höglinger, G. U., & Storch, A. (2009) · Stem Cells · doi:10.1002/stem.21 · Cited by 47
Self-citationBidirectional modulation of Alzheimer phenotype by alpha-synuclein in mice and primary neurons
Khan, S. S., LaCroix, M., Boyle, G., Sherman, M. A., Brown, J. L., Amar, F., Aldaco, J., Lee, M. K., Bloom, G. S., & Lesné, S. E. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1886-z · Cited by 41
Singh, K., Singh, S., Singhal, N. K., Sharma, A., Parmar, D., & Singh, M. P. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.03.015 · Cited by 41
Milošević, J., Schwarz, S. C., Ogunlade, V., Meyer, A. K., Storch, A., & Schwarz, J. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-25 · Cited by 44
“Pathologic DNs aberrantly expressed proliferating cell nuclear antigen (PCNA) and the transcription factor E2F-1, both in vitro and in vivo, following 1-methyl-4-phenylpyridinium (MPP+) intoxication, as well as in PD patients [33].”
BackgroundPatrício, P., Mateus-Pinheiro, A., Sousa, N., & Pinto, L. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8422-x · Cited by 38
“These changes in cell cycle dynamics, as observed in several disease states [90-92], further reinforce the need for additional studies examining the role of core cell cycle players as targets for disruption.”
BackgroundNeuroepigenetics of Aging and Age-Related Neurodegenerative Disorders
Lardenoije, R., Pishva, E., Lunnon, K., & van den Hove, D. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2018.04.008 · Cited by 41
Regulatory miRNA–mRNA Networks in Parkinson’s Disease
Santos‐Lobato, B. L., Vidal, A. F., & Ribeiro‐dos‐Santos, Â. (2021) · Cells · doi:10.3390/cells10061410 · Cited by 38
“In PD, there is an overexpression of mitotic-associated proteins, such as cyclins and cyclindependent kinases, in the substantia nigra of postmortem patients with PD and an MPTP mouse model of PD, resulting in apoptosis of dopaminergic neurons [41,42].”
BackgroundRetinal degeneration depends on Bmi1 function and reactivation of cell cycle proteins
Zencak, D., Schouwey, K., Chen, D., Ekström, P. A. R., Tanger, E., Bremner, R., van Lohuizen, M., & Arsenijévic, Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108297110 · Cited by 41
“This phenomenon has been observed in mouse models of Alzheimer’s disease (6, 7), Parkinson disease (8), and amyotrophic lateral sclerosis (9), where postmitotic neurons start to express nuclear cyclin-dependent kinase 4 (CDK4), implicated in the reentry into the cell cycle and in the transition from G1 to S phase.”
BackgroundInfluentialAlvira, D., Yeste‐Velasco, M., Folch, J., Casadesús, G., Smith, M. A., Pallàs, M., & Camins, A. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21427 · Cited by 38
“…neurons is a consequence of DNA damage (Keramaris et al., 2003; Kruman, 2004; Krantic et al., 2005; Schwartz et al., 2007), and previous studies working with DNA neurotoxins found an association between neuronal apoptosis and the process of cell-cycle reentry (Kruman, 2004; Hoglinger et al., 2007).”
BackgroundGonzález‐Cota, A. L., Martínez-Flores, D., Rosendo‐Pineda, M. J., & Vaca, L. A. (2024) · Cell Calcium · doi:10.1016/j.ceca.2024.102856 · Cited by 42
Cyclin F: A component of an E3 ubiquitin ligase complex with roles in neurodegeneration and cancer
Galper, J., Rayner, S. L., Hogan, A. L., Fifita, J. A., Lee, A., Chung, R. S., Blair, I. P., & Yang, S. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.06.011 · Cited by 37
Region- and Cell-specific Aneuploidy in Brain Aging and Neurodegeneration
Shepherd, C. E., Yang, Y., & Halliday, G. M. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.01.050 · Cited by 37
LncRNA-T199678 Mitigates α-Synuclein-Induced Dopaminergic Neuron Injury via miR-101-3p
Bu, L.-L., Xie, Y., Lin, D., Chen, Y., Jing, X., Liang, Y., Peng, S., Huang, K., & Tao, E. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.599246 · Cited by 36
Hernández‐Ortega, K., Quiroz‐Baez, R., & Arias, C. (2011) · Neuroscience Bulletin · doi:10.1007/s12264-011-1002-z · Cited by 38
Hsieh, M.-H., Meng, W.-Y., Liao, W.-C., Weng, J.-C., Li, H.-H., Su, H.-L., Lin, C.-L., Hung, C.-S., & Ho, Y.-J. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.05.015 · Cited by 35
“The lack of changes in the BrdU-positive cell number in the SNc after MPTP lesioning is in agreement with some earlier studies (Mao et al., 2001; Kay and Blum, 2000; Chen et al., 2005; Hoglinger et al., 2007).”
ResultScratch2 Prevents Cell Cycle Re-Entry by Repressing miR-25 in Postmitotic Primary Neurons
Rodríguez-Aznar, E., Barrallo‐Gimeno, A., & Nieto, M. A. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4459-12.2013 · Cited by 35
“For example, cell cycle components are deregulated in Alzheimer s or Parkinson s diseases (Höglinger et al., 2007; Varvel et al., 2009) and the miR106b 25 cluster is upregulated in human gastric cancer (Petrocca et al.”
BackgroundTokarz, P., Kaarniranta, K., & Błasiak, J. (2016) · Rejuvenation Research · doi:10.1089/rej.2015.1717 · Cited by 40
“25,28,63 The cell cycle re-entry markers were increased in HD and were co-localized with cell death markers.”
InfluentialBehbahanipour, M., Peymani, M., Salari, M., Hashemi, M., Nasr‐Esfahani, M. H., & Ghaedi, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-50256-3 · Cited by 40
Smajić, S., Prada‐Medina, C. A., Landoulsi, Z., Dietrich, C., Jarazo, J., Henck, J., Balachandran, S., Pachchek, S., Morris, C. M., Antony, P. M. A., et al. (2020) · medRxiv · doi:10.1101/2020.09.28.20202812 · Cited by 34
Neuroprotective Transcription Factors in Animal Models of Parkinson Disease
de Thé, F.-X. B., Rekaik, H., Prochiantz, A., Fuchs, J., & Joshi, R. L. (2015) · Neural Plasticity · doi:10.1155/2016/6097107 · Cited by 41
“regulation may lead to neurodegeneration [136, 137], often marked by cell cycle entry prior to death [138, 139].”
Fiala, M., Avagyan, H., Merino, J. J., Bernas, M. J., Valdivia, J. M., Monteros, A. E. D. L., Witte, M. H., & Weinand, M. E. (2012) · Pathophysiology · doi:10.1016/j.pathophys.2012.02.003 · Cited by 36
Metadata
- Authors
- Höglinger, G. U., Breunig, J. J., Depboylu, C., Rouaux, C., Michel, P. P., Alvarez-Fischer, D., Boutillier, A.-L., DeGregori, J., Oertel, W. H., Rakic, P., Hirsch, E. C., & Hunot, S.
- Affiliations
- Inserm (FR)
- Yale University (US)
- Philipps University of Marburg (DE)
- *Department of Experimental Neurology, Philipps University, 35039 Marburg, Germany;
- University of Colorado Denver (US)
- Department of Experimental Neurology and Therapeutics, Unité Mixte de Recherche 679, Institut National de la Santé et de la Recherche Médicale, 75013 Paris, France;
- Corresponding author
- Rakic, Pasko
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2007-02-27
- Volume
- 104
- Issue
- 9
- Pages
- 3585-3590
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1805567
- OpenAlex
- W2092598865
- Cited by
- 276
- References
- 25
- Citations by year
- 2026: 10 · 2025: 10 · 2024: 8 · 2023: 7 · 2022: 6 · 2021: 14 · 2020: 12 · 2019: 16 · 2018: 11 · 2017: 9 · 2016: 9 · 2015: 22 · 2014: 17 · 2013: 19 · 2012: 16
- FWCI
- 16.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- European Commission (LSHM-CT-2003-503330)
- Bundesministerium für Bildung und Forschung (01GO0201, BMBF-01GN0513, 01GN0513)
- National Institute of Mental Health (R24MH068855, R24MH68855)
- National Cancer Institute (R01CA077314)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Parkinson's disease, dopaminergic neurons, substantia nigra, retinoblastoma protein, E2F1, cell cycle, neuronal cell death, MPTP, MPP+, DNA replication, neuroprotection, postmitotic neurons
- MeSH terms
- Analysis of Variance, Animals, Chromatography, High Pressure Liquid, Gene Expression Regulation, Humans, Immunohistochemistry, Interneurons, Male, Mice, Inbred C57BL, Parkinson Disease, Substantia Nigra, Signal Transduction, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 1-Methyl-4-phenylpyridinium, Oligonucleotides, Antisense, Apoptosis, In Situ Hybridization, Mice, Knockout, E2F1 Transcription Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.